Poster Abstracts - C717

Displaying 1 - 10 of 290
First
1
2
3
4
5
Last

Articles

Dendritic Cell-based Vaccine for Complementary Therapy of High Grade Glioma Patients using the CliniMACS Platform for Large-scale Clinical Production
Identification
1001
Modeling Tumor Immuno-Dynamics to Predict Patient Survival & Immunotherapy Efficacy
Identification
1002
Targeting myeloid derived suppressor cells to attenuate glioblastoma growth
Identification
1003
An analysis of expression of Immune checkpoint biomarkers in 15,454 patients with adverse pathology after radical prostatectomy: initial results from the Decipher GRID
Identification
1004
Class II-restricted tumor antigens can function to either promote or inhibit vaccine induced protective anti-tumor responses
Identification
1005
Engineering adoptive T cell therapy for efficacy in ovarian cancer
Identification
1007
Myeloid Derived Suppressor Cells Arising from Tumor Resections Severely Suppresses Natural Killer Cells ex vivo
Identification
1008
Depletion of tumor-infiltrating regulatory T cells with anti-CD25 requires Fc-optimization and synergizes with PD-1 blockade to eradicate established tumors
Identification
1010
Humanized mouse; A model for understanding tumor-immune system interactions
Identification
1012
HIFU improves the therapeutic efficacy of dendritic cell vaccine in mouse melanoma model
Identification
1014

Displaying 1 - 10 of 290
First
1
2
3
4
5
Last

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.